Comparative effects of Glucagon-Like Peptide-2 (GLP-2), Growth Hormone (GH), and Keratinocyte Growth Factor (KGF) on markers of gut adaptation after massive small bowel resection in rats

Journal of Parenteral and Enteral Nutrition

Volumn 28, Issue 6, 2004, Pages 399-409

  Washizawa, Naohiro ^a,b   Gu, Li H ^b   Gu, Liang ^b   Openo, Kyle P ^b   Jones, Dean P ^b   Ziegler, Thomas R ^b,c  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 2; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; RECOMBINANT KERATINOCYTE GROWTH FACTOR; TREFOIL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL GROWTH; CONTROLLED STUDY; CRYPT CELL; DRUG EFFECT; GOBLET CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONAL THERAPY; INTESTINE FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHORT BOWEL SYNDROME; SMALL INTESTINE; SMALL INTESTINE MUCOSA; SMALL INTESTINE RESECTION; WESTERN BLOTTING;

ANIMALIA; LOTUS;

EID: 7744245303     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607104028006399     Document Type: Article

References (65)

1. Ziegler TR, Evans ME, Fernandez-Estivariz C, Jones DP. Trophic and cytoprotective nutrition for intestinal adaptation, mucosal repair, and barrier function. Annu Rev Nutr. 2003;23:229-261.
2. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124:1111-1134.
3. Hanson WR, Osborne JW, Sharp JG. Compensation by the residual intestine after intestinal resection in the rat, I: influence of amount of tissue removed. Gastroenterology. 1977;42:692-700.
4. Hanson WR, Osborne JW, Sharp JG. Compensation by the residual intestine after intestinal resection in the rat, II: influence of postoperative time interval. Gastroenterology. 1977;42:701-705.
5. Ljungmann K, Grofte T, Kissmeyer-Nielsen P, et al. GH decreases hepatic amino acid degradation after small bowel resection in rats without enhancing bowel adaptation. Am J Physiol. 2000;279:G700-G706.
6. Tappenden KA, Thomson AB, Wild GE, McBurney MI. Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology. 1997;112:792-802.
7. Ziegler TR, Mantell MP, Chow JC, Rombeau JL, Smith RJ. Gut adaptation and the insulin-like growth factor system: regulation by glutamine and insulin-like growth factor-I administration. Am J Physiol. 1996;271:G866-G875.
8. Ziegler TR, Mantell MP, Chow JC, Rombeau JL, Smith RJ. Intestinal adaptation after extensive small bowel resection: differential changes in growth and insulin-like growth factor system messenger ribonucleic acids in jejunum and ileum. Endocrinology. 1998;139:3119-3126.
9. Erwin CR, Helmrath MA, Shin CE, Falcone RA Jr, Stern LE, Warner BW. Intestinal overexpression of EGF in transgenic mice enhances adaptation after small bowel resection. Am J Physiol. 1999;277:G533-G540.
10. Nundy S, Malamud D, Obertop H, Sczerban J, Malt RA. Onset of cell proliferation in the shortened gut: colonic hyperplasia after ileal resection. Gastroenterology. 1977;72:263-266.
11. Urban E, Starr PE, Michel AM. Morphologic and functional adaptations of large bowel after small-bowel resection in the rat. Dig Dis Sci. 1983;28:265-272.
12. Mantell MP, Ziegler TR, Roth BA, et al. Resection-induced colonic adaptation is augmented by IGF-I and associated with upregulation of colonic IGF-I mRNA. Am J Physiol. 1995;269:G974-G980.
13. O'Keefe SJ, Raymond MW, Bennet WM, Oswald B, Nelson DK, Shorter RG. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology. 1994;107:379-388.
14. Ziegler TR, Fernandez-Estivariz C, Gu LH, et al. Distribution of the H+/peptide transporter PepT1 in human intestine: up-regulated expression in the colonic mucosa of patients with short-bowel syndrome. Am J Clin Nutr. 2002;75:922-930.
15. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short-bowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg. 1995;222:243-254.
16. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient abuthionine sulfoximiderption and nutritional status in short-bowel patients with no colon. Gastroenterology. 2001;120:806-815.
17. Jeppesen PB, Blosch CM, Lopansri JB, et al. ALX-0600, a dipeptidyl peptidase-IV resistant glucagon-like peptide-2 (GLP-2) analog, improves intestinal function in SBS (short bowel syndrome) patients with a jejunostomy [abstract]. Gastroenterology. 2002;122(Suppl):A191.
18. 0 and oligopeptide transporter 1 mRNA expression after enterectomy. JPEN J Parenter Enteral Nutr. 2001;25:65-72.
19. Benhamou PH, Canarelli JP, Leroy C, et al. Stimulation by recombinant human growth hormone of growth and development of remaining bowel after subtotal ileojejunectomy in rats. J Pediatr Gastroenterol Nutr. 1994;18:446-452
20. Benhamou PH, Canarelli JP, Richard S, et al. Human recombinant growth hormone increases small bowel lengthening after massive small bowel resection in piglets. J Pediatr Surg. 1997;32:1332-1336.
21. Dahly EM, Guo Z, Ney DM. IGF-I augments resection-induced mucosal hyperplasia by altering enterocyte kinetics. Am J Physiol. 2003;285:R800-R808.
22. Eizaguirre I, Aldazabal P, Barrena MJ, et al. Effect of growth hormone, epidermal growth factor, and insulin on bacterial translocation in experimental short bowel syndrome. J Pediatr Surg. 2000;35:692-695.
23. Gillingham MB, Dahly EM, Carey HV, Clark MD, Kritsch KR, Ney DM. Differential jejunal and colonic adaptation due to resection and IGF-I in parenterally fed rats. Am J Physiol. 2000;278:G700-G709.
24. Gomez de Segura IA, Afuilera MJ, Codesal J, et al. Comparative effects of growth hormone in large and small bowel resection in the rat. J Surg Res. 1996;62:5-10.
25. Graham J, Martin G, Meddings JB, Sigalet DL. Epidermal growth factor improves nutritional outcome in a rat model of short bowel syndrome. J Pediatr Surg. 2002;37:765-769.
26. Gu Y, Wu ZH, Xie JX, et al. Effects of growth hormone (rhGH) and glutamine supplemented parenteral nutrition on intestinal adaptation in short bowel rats. Clin Nutr. 2001;20:159-166.
27. Hirotani Y, Yamamoto K, Yanaihara C. Balaspiri L, Yanaihara N, Kurokawa K. Distinctive effects of glicentin, GLP-1 and GLP-2 on adaptive response to massive distal small intestine resection in rats. Ann N Y Acad Sci. 2000;921:460-463.
28. Iannoli P, Miller JH, Ryan CK, Gu LH, Ziegler TR, Sax HC. Epidermal growth factor and human growth hormone accelerate adaptation after massive enterectomy in an additive, nutrient-dependent, and site-specific fashion. Surgery. 1997;122:721-728.
29. Iannoli P, Miller JH, Ryan CK, Gu LH, Ziegler TR, Sax HC. Human growth hormone induces system B transport in short bowel syndrome. J Surg Res. 1997;69:150-158.
30. Johnson WF, DiPalma CR, Ziegler TR, Scully S, Farrell CL. Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome. Vet Surg. 2000;29:17-27.
31. Lukish J, Schwartz MZ, Rushin JM, Riordan GP. A comparison of the effect of growth factors on intestinal function and structure in short bowel syndrome. J Pediatr Surg. 1997;32:1652-1655.
32. Ray EC, Avissar NE, Vukcevic D, et al. Growth hormone and epidermal growth factor together enhance amino acid transport systems B0,+ and A in remnant small intestine after massive enterectomy. J Surg Res. 2003;115:164-170.
33. Scott RB, Kirk D, MacNaughton WK, Meddings JB. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol. 1998;275:G911-G921.
34. Shin CE, Helmrath MA, Falcone RA Jr, et al. Epidermal growth factor augments adaptation following small bowel resection: optimal dosage, route, and timing of administration. J Surg Res. 1998;77:11-16.
35. Shulman DI, Hu CS, Duckett G. Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection. J Pediatr Gastroenterol Nutr. 1992;14:3-11.
36. Sigalet DL, Martin GR. Hormonal therapy for short bowel syndrome. J Pediatr Surg. 2000;35:360-362.
37. Yang H, Wildhaber BE, Teitelbaum DH. Keratinocyte growth factor improves epithelial function after massive small bowel resection. JPEN J Parenter Enteral Nutr. 2003;27:198-206.
38. Zhou X, Li YX, Li N, Li JS. Glutamine enhances the gut-trophic effect of growth hormone in rat after massive small bowel resection. J Surg Res. 2001;99:47-52.
39. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology. 1997;113:1074-1081.
40. Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology. 2003;124:293-302.
41. Hi T-cell transfer mouse modes of inflammatory bowel disease. Am J Physiol. 2002;282:G690-G701.
42. Drucker DJ. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology. 2002;122:531-544.
43. Williams KL, Fuller CR, Dieleman LA, et al. Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology. 2001;120:925-937.
44. Fernandez-Estivariz C, Gu LH, Gu L, et al. Trefoil peptide expression and goblet cell number in rat intestine: effects of KGF and fasting-refeeding. Am J Physiol. 2003;284:R564-R573.
45. Marchbank T, Cox HM, Goodlad RA, et al. Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice. J Biol Chem. 2001;276:24088-24096.
46. Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996;274:262-265.
47. Wong WM, Poulsom R, Wright NA. Trefoil peptides. Gut. 1999;44:890-895.
48. Rubin DC, Swietlicki EA, Iordanov H, Fritsch C, Levin MS. Novel goblet cell gene related to IgGFcgammaBP is regulated in adapting gut after small bowel resection. Am J Physiol. 2000;279:G1003-G1010.
49. Estivariz CF, Jonas CR, Gu LH, et al. Gut-trophic effects of keratinocyte growth factor in rat small intestine and colon during enteral refeeding. JPEN J Parenter Enteral Nutr. 1998;22:259-267.
50. Jonas CR, Gu LH, Nkabyo YS, et al. Glutamine and KGF each regulate extracellular thiol/disulfide redox and enhance proliferation in Caco-2 cells. Am J Physiol. 2003;285:R1421-R1429.
51. Jones DP. Redox potential of the GSH/GSSG couple: assay and biological significance. Methods Enzymol. 2002;348:93-112.
52. Hutter DE, Till BG, Greene JJ. Redox state changes in density-dependent regulation of proliferation. Exp Cell Res. 1997;232:435-438.
53. Jonas CR, Estívariz CF, Jones DP, et al. Keratinocyte growth factor enhances glutathione redox state in rat intestinal mucosa during nutritional repletion. J Nutr. 1999;127:1278-1284.
54. Tsai C-H, Hill M, Asa SL, et al. Intestinal growth-promoting properties of glucagon-like peptide 2 in mice. Am J Physiol. 1997;273:E77-E84.
55. Drucker DJ, DeForest L, Brubaker PL. Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2. Am J Physiol. 1997;273:G1252-G1262.
56. Lanbarca C, Kenneth P. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1979;102:344-352.
57. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
58. Estívariz CF, Gu LH, Scully S, et al. Regulation of keratinocyte growth factor (KGF) and KGF receptor mRNAs by nutrient intake and KGF administration in rat intestine. Dig Dis Sci. 2000;45:736-743.
59. Lobie PE, Breipohl W, Waters MJ. Growth hormone receptor expression in the rat gastrointestinal tract. Endocrinology. 1990;126:299-306.
60. Chance WT, Foley-Nelson T, Thomas I, Balasubramaniam A. Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2. Am J Physiol. 1997;273:G559-G563.
61. Burrin DG, Stoll B, Jiang R, et al. GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis. Am J Physiol. 2000;279:G1249-G1256.
62. Lo HC, Ney DM. GH and IGF-I differentially increase protein synthesis in skeletal muscle and jejunum of parenterally fed rats. Am J Physiol. 1996;271:E872-E878.
63. Benjamin MA, McKay DM, Yang PC, et al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut. 2000;47:112-119.
64. Park JH, Vanderhoof JA. Growth hormone did not enhance mucosal hyperplasia after small-bowel resection. Scand J Gastroenterol. 1996;31:349-354.
65. Martensson J, Jain A, Meister A. Glutathione is required for intestinal function. Proc Natl Acad Sci USA. 1989;87:1715-1719.